Are you a medical student attending ASTRO? Reminder that you are invited to come hang out with us at our reception at House of Blues from 6-8pm on 10/2! We would love to meet you and tell you what makes our department special! #ASTRO #RadOnc #MedStudentTwitter

Reminder to all prospective #RadOnc residency #match applicants to come visit with us at our upcoming virtual Meet & Greet session on 10/11 at 7pm EST! There’s still time to sign up - link below! Looking forward to meeting you! ASTRO ACRO - American College of Radiation Oncology ARRO Jessica Frakes

We are thrilled to announce our #Match2024 residents, Samantha Webking and Levi Martinka! Congratulations, and welcome to the family! We are so excited for you to join 🎉🥳🍾

Excited to announce our upcoming Virtual Meet & Greet session! If you are a medical student interested in learning more about Moffitt Rad Onc, please sign up at the link below. Sign up link: docs.google.com/spreadsheets/d…

⚠️TONIGHT‼️‼️ Looking forward to meeting you all!

Moffitt Cancer Center ASTRO The MoffittRadOnc residents are giving a ton of great presentations! Please be sure to check them out ! JM Bryant, MD Ruben J. Cruz, MD Jessica Frakes Emily Keit Vaseem Khatri Justyn Nakashima, DO John Peterson

At #ASTRO24, Justyn Nakashima, DO (Justyn Nakashima, DO) presents the patterns of CNS failures in relapse/refractory large B-cell lymphoma patients with secondary CNS disease following CAR T therapy. #MoffittASTRO24 ⏰: 10/1 4:00 p.m. - 5:00 p.m. EDT 📍: Hall C Learn more ➡️

Moffitt study presented at #ASTRO24 highlights the potential for improved outcomes by targeting extramedullary disease before cell therapy. #MoffittASTRO24 #RadOnc ASTRO Justyn Nakashima, DO bit.ly/3Y3uTHX

During #ASTRO24, Justyn Nakashima, DO (Justyn Nakashima, DO) highlights the patterns of failure in multiple myeloma with extramedullary disease following anti-BCMA directed CAR T. #MoffittASTRO24 ⏰: 10/2 8:20 p.m. - 8:30 a.m. EDT 📍: Room 1144 Learn more ➡️ bit.ly/3BkX7VU

Great insights from #ASTRO24! I discussed cutting-edge radiation therapy with Justyn Nakashima, DO (Justyn Nakashima, DO). His research shows that targeting extramedullary disease before cell therapy could improve outcomes. Read more: bit.ly/3BkX7VU #MoffittASTRO24

Fantastic interview with JM Bryant, MD talking to Justyn Nakashima, DO from MoffittRadOnc discussing his project on patterns of failure in patients with multiple myeloma with extramedullary disease following CAR T-cell therapy and possible role of bridging RT. Excellent work! 👏

Justyn Nakashima, DO (Justyn Nakashima, DO) shares that radiation therapy may boost the effectiveness of CAR T-cell treatment in aggressive #MultipleMyeloma. Learn more ➡️bit.ly/3TMp5jz #ASTRO24 #MoffittASTRO24

During #ASTRO24, Justyn Nakashima, DO (Justyn Nakashima, DO) presents the patterns of CNS failures in relapse/refractory large B-cell lymphoma patients with secondary CNS disease following CAR T therapy. Learn more ➡️ bit.ly/3TMp5jz #MoffittASTRO24 ASTRO

The team having fun and sharing their work at #ASTRO24 Moffitt Cancer Center ASTRO 💪🏽🧬

Congratulations to Jacqueline Andreozzi, PhD, DABR on winning the ARRO educator of the year award, Justyn Nakashima, DO on winning the clinical award, and to JM Bryant, MD on winning the leadership award! 💪🏽💥Jessica Frakes Stephen Rosenberg, MD

Our multi institution series on T-DXd and SRS for HER2+ and HER2 Low Brain Mets was just published in npj Journals Breast Cancer! nature.com/articles/s4152…

Thank you so much to Dr. Einhorn for being our honored guest at Resident Research Day ! Congrats to all the residents and their great presentations ! MoffittRadOnc Moffitt Cancer Center Kosj Yamoah MD, PhD Jessica Frakes JM Bryant, MD Ruben J. Cruz, MD #radonc

Congratulations to the new members of our #RadOnc family here at Moffitt Cancer Center 🫶🏽🔥

From #ASTRO25 : Justyn Nakashima, DO (Justyn Nakashima, DO) shares institutional outcomes of SBRT for extracranial oligometastatic renal cell carcinoma during the poster Q&A. Results indicate that SBRT is safe and effective, delaying systemic

At #ASTRO25, Preston Perez, BA (Preston Perez), discussed outcomes of bridging radiotherapy before CAR T therapy in multiple myeloma. Findings show that bridging radiotherapy before anti-BCMA CAR T therapy in relapsed/refractory multiple myeloma was safe, controlled irradiated